Up to 6 years follow-up of people with MS (n=250) receiving cladribine
View/ Open
Published version
Embargoed until: 5555-01-01
Reason: Version not permitted.
Embargoed until: 5555-01-01
Reason: Version not permitted.
Volume
27
Pagination
546 - 547
Issue
ISSN
1352-4585